1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α with Reduced Lipophilicity: Synthesis, Biological Activity, Metabolic Stability, Solubility, Bioavailability, And Topical in Vivo Activity
- 29 June 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (14) , 5165-5178
Abstract
Indole-5-carboxylic acids with 3-aryloxy-2-oxopropyl residues in position 1 were previously reported to be potent inhibitors of human cytosolic phospholipase A2α (cPLA2α). In continuation of our attempts to develop clinical active cPLA2α inhibitors, a series of structurally related indole-5-carboxylic acids with reduced lipophilicity was synthesized and tested for cPLA2α-inhibitory potency. Furthermore, the thermodynamic solubility of these compounds and their metabolic stability in rat liver microsomes were evaluated. With an IC50 of 0.012 μM against the isolated enzyme, compound 36 was one of the most potent cPLA2α inhibitors that emerged during the structure−activity relationship study. Concomitantly, 36 possessed the highest water solubility (212 μg/mL at pH 7.4) of all new target compounds. Despite these favorable properties, peroral application of 36 (100 mg/kg) in mice only led to low concentrations of the substance in blood plasma. A very high plasma clearance was observed after intravenous administration of 36 (10 mg/kg). However, in a topical murine model of contact dermatitis, 36 showed a pronounced anti-inflammatory in vivo activity.Keywords
This publication has 42 references indexed in Scilit:
- Properties of the Group IV phospholipase A2 familyProgress in Lipid Research, 2006
- Biochemical properties and pathophysiological roles of cytosolic phospholipase A2sBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006
- Cytosolic phospholipase A2α reigns supreme in arthritis and bone resorptionTrends in Immunology, 2004
- Cytosolic Phospholipase A2α–deficient Mice Are Resistant to Collagen-induced ArthritisJournal of Experimental Medicine, 2003
- An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with InflammationJournal of Experimental Medicine, 2003
- Specific physiological roles of cytosolic phospholipase A2 as defined by gene knockoutsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2Nature Immunology, 2000
- Role of cytosolic phospholipase A2 in allergic response and parturitionNature, 1997
- Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2Nature, 1997
- Patent Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: The search for inhibitors of the phospholipases A2Expert Opinion on Therapeutic Patents, 1995